NEW YORK, August 25, 2026--(BUSINESS WIRE)--Concordare Trials closed a funding round led by Surface Ventures with participation from Techstars, Innovation Works, Gaingels, and individual investors.
Hosted on MSN
What happens when protocol data finally flows
Rob DiCicco, vice president of portfolio management, and Bill Illis, workstream leader, digital data flow at TransCelerate BioPharma, highlight the advantages of digital protocols for clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results